Pfizer Inc.’s PFE, +0.45% $5.4 billion acquisition of Global Blood Therapeutics Inc. GBT, -0.02% is the latest sign that cash-flush drug makers are ready to jump back into dealmaking. That Read more
Tag: GBT
Pfizer agrees to buy Global Blood Therapeutics in deal valued at $5.4 billion: WSJ
Pfizer Inc. PFE, -1.18% has reached an agreement to buy Global Blood Therapeutics Inc. [s :gbt] in a deal valued at $5.4 billion, the Wall Street Journal reported, citing people Read more